Updating!
Coming soon!
Coming soon!
Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by DAVIS COMMODITIES Ltd
Filings | Format | Description | Filed/Effective | File/Film Number |
---|---|---|---|---|
NT 20-F | Document | Notice under Rule 12b25 of inability to timely file all or part of an annual report of form 20-F Acc-no: 0001683168-24-002838 (34 Act) Size: 21 KB |
Apr-30-2024 | 24894564 |
SC 13D | Document | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Acc-no: 0001683168-24-002337 (34 Act) Size: 97 KB |
Apr-12-2024 | 24840966 |
SC 13G | Document | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001683168-24-000550 (34 Act) Size: 33 KB |
Jan-30-2024 | 24577414 |
SC 13G | Document | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001683168-24-000548 (34 Act) Size: 55 KB |
Jan-30-2024 | 24577407 |
6-K | Document | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001683168-23-009138 (34 Act) Size: 480 KB |
Dec-29-2023 | 231525530 |
6-K | Document | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001683168-23-007580 (34 Act) Size: 18 KB |
Nov-02-2023 | 231370845 |
6-K | Document | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001683168-23-007239 (34 Act) Size: 15 KB |
Oct-18-2023 | 231331013 |
6-K | Document | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001683168-23-006614 (34 Act) Size: 49 KB |
Sep-22-2023 | 231270257 |
424B4 | Document | Prospectus filed pursuant to Rule 424(b)(4) Acc-no: 0001683168-23-006563 (33 Act) Size: 2140 KB |
Sep-20-2023 | 231265598 |
EFFECT | Document | Acc-no: 9999999995-23-002685 (33 Act) Size: 1 KB | Sep-18-2023 | 231262416 |
CERT | Document | Acc-no: 0001354457-23-000678 (34 Act) Size: 140 KB | Sep-18-2023 | 231261026 |
8-A12B | Document | Form for the registration / listing of a class of securities on a national securities exchange pursuant to section 12(b) Acc-no: 0001683168-23-006440 (34 Act) Size: 18 KB |
Sep-14-2023 | 231255400 |
CORRESP | Document | A correspondence can be sent as a document with another submission type or can be sent as a separate submission. Acc-no: 0001683168-23-006427 ( Act) Size: 7 KB |
Sep-14-2023 | |
CORRESP | Document | A correspondence can be sent as a document with another submission type or can be sent as a separate submission. Acc-no: 0001683168-23-006424 ( Act) Size: 11 KB |
Sep-14-2023 | |
FWP | Document | Filing under Securities Act Rules 163/433 of free writing prospectuses Acc-no: 0001683168-23-006295 (34 Act) Size: 2342 KB |
Sep-06-2023 | 231238350 |
CORRESP | Document | A correspondence can be sent as a document with another submission type or can be sent as a separate submission. Acc-no: 0001683168-23-006187 ( Act) Size: 16 KB |
Aug-31-2023 | |
F-1/A | Document | Amendment to Registration statement for securities of certain foreign private issuers Acc-no: 0001683168-23-006185 (33 Act) Size: 2211 KB |
Aug-31-2023 | 231227692 |
UPLOAD | Document | Acc-no: 0000000000-23-009604 ( Act) Size: 43 KB | Aug-30-2023 | |
F-1/A | Document | Amendment to Registration statement for securities of certain foreign private issuers Acc-no: 0001683168-23-006000 (33 Act) Size: 2522 KB |
Aug-23-2023 | 231194968 |
CORRESP | Document | A correspondence can be sent as a document with another submission type or can be sent as a separate submission. Acc-no: 0001683168-23-004742 ( Act) Size: 23 KB |
Jul-10-2023 |
Recent 20 filings. View all DAVIS COMMODITIES Ltd filings
young lad who new his job ansered questions and new what was best for me.
Very good communication and delivery made within the timeframe I was advised of
Thanks I look forward to using the product to improve my skin tone
Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.
© 2022 CompaniesBIO.Com. All rights reserved. Operated by